Loss of RBMS1 promotes anti-tumor immunity through enabling PD-L1 checkpoint blockade in triple-negative breast cancer

Jinrui Zhang(Dalian Medical University), Yang Wang(The Affiliated Yongchuan Hospital of Chongqing Medical University)
Cell Death and Differentiation
May 10, 2022
Cited by 93


Related Papers